{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:15Z","timestamp":1792784295552,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Netherlands Toxicogenomics Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.reprotox.2014.07.082","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T16:32:31Z","timestamp":1407515551000},"page":"101-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs"],"prefix":"10.1016","volume":"49","author":[{"given":"Anna","family":"Beker van Woudenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cor","family":"Snel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eke","family":"Rijkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didima","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldert","family":"Piersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Wolterbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2014.07.082_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.reprotox.2010.05.014","article-title":"Early transcriptional responses in mouse embryos as a basis for selection of molecular markers predictive of valproic acid teratogenicity","volume":"30","author":"Kultima","year":"2010","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/026119290903700314","article-title":"A review of the implementation of the embryonic stem cell test (EST)","volume":"37","author":"Marx-Stoelting","year":"2009","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2010.05.007","article-title":"Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics","volume":"247","author":"West","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.reprotox.2013.03.002","article-title":"Evaluation of an alternative in vitro test battery for detecting reproductive toxicants","volume":"38","author":"Piersma","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ntt.2009.06.005","article-title":"Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science","volume":"32","author":"Breier","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.reprotox.2010.05.012","article-title":"The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants","volume":"30","author":"Schenk","year":"2010","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0040","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/bjp.2008.249","article-title":"Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery","volume":"154","author":"Barros","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425255.2011.562197","article-title":"Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models","volume":"7","author":"Sukardi","year":"2011","journal-title":"Expert Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0050","series-title":"Drug discovery and evaluation: safety and pharmacokinetic assays","first-page":"605","article-title":"Zebrafish in drug discovery: safety assessment","author":"Hill","year":"2013"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/toxsci\/kfi110","article-title":"Zebrafish as a model vertebrate for investigating chemical toxicity","volume":"86","author":"Hill","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0060","series-title":"High-throughput screening methods in toxicity testing","first-page":"371","article-title":"Zebrafish development: high-throughput test systems to assess developmental toxicity","author":"Padilla","year":"2013"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tiv.2011.01.005","article-title":"Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies","volume":"25","author":"Hermsen","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.reprotox.2011.10.018","article-title":"Zebrafish developmental screening of the ToxCast\u2122 Phase I chemical library","volume":"33","author":"Padilla","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/bdrb.20223","article-title":"Development of a zebrafish embryo teratogenicity assay and quantitative prediction model","volume":"89","author":"Brannen","year":"2010","journal-title":"Birth Defects Res B: Dev Reprod"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.reprotox.2011.08.003","article-title":"Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds","volume":"33","author":"Selderslaghs","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.reprotox.2013.06.067","article-title":"A category approach to predicting the developmental (neuro)toxicity of organotin compounds: the value of the zebrafish (Danio rerio) embryotoxicity test (ZET)","volume":"41","author":"Beker van Woudenberg","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ntt.2009.04.066","article-title":"Acute neuroactive drug exposures alter locomotor activity in larval zebrafish","volume":"32","author":"Irons","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ntt.2012.03.002","article-title":"Locomotor activity assay in zebrafish larvae: influence of age, strain and ethanol","volume":"34","author":"de Esch","year":"2012","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ntt.2013.01.003","article-title":"Assessment of the developmental neurotoxicity of compounds by measuring locomotor activity in zebrafish embryos and larvae","volume":"37","author":"Selderslaghs","year":"2013","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/B:ECTX.0000003034.69538.eb","article-title":"Proteomics in zebrafish exposed to endocrine disrupting chemicals","volume":"12","author":"Shrader","year":"2003","journal-title":"Ecotoxicology"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.taap.2013.05.037","article-title":"Transcriptomic analysis in the developing zebrafish embryo after compound exposure: individual gene expression and pathway regulation","volume":"272","author":"Hermsen","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.reprotox.2011.06.119","article-title":"Zebrafish developmental toxicity assay: a fishy solution to reproductive toxicity screening, or just a red herring","volume":"32","author":"Van den Bulck","year":"2011","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0120","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0125","doi-asserted-by":"crossref","DOI":"10.1093\/biohorizons\/hzt003","article-title":"A scientific review: mechanisms of valproate-mediated teratogenesis","volume":"6","author":"Lloyd","year":"2013","journal-title":"Biosci Horizons"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/bdrc.20082","article-title":"Inhibition of histone deacetylase as a new mechanism of teratogenesis","volume":"78","author":"Menegola","year":"2006","journal-title":"Birth Defects Res C: Embryo Today Rev"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/dev.065938","article-title":"Retinoic acid signalling during development","volume":"139","author":"Rhinn","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0140","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","article-title":"Teratogenic effects of antiepileptic drugs","volume":"11","author":"Tomson","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.reprotox.2006.03.014","article-title":"Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy","volume":"22","author":"Ornoy","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samr\u00e9n","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0890-6238(91)90090-3","article-title":"Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies","volume":"5","author":"Finnell","year":"1991","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0160","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yebeh.2012.05.010","article-title":"Differential effects of antiepileptic drugs on neonatal outcomes","volume":"24","author":"Pennell","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1520-6866(1990)2:1<61::AID-TCM1770020107>3.0.CO;2-O","article-title":"The relative teratogenic index and teratogenic potency: proposed components of developmental toxicity risk assessment","volume":"2","author":"Fabro","year":"1982","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0170","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/01.fbp.0000236268.79923.18","article-title":"The effects of chronic administration of ethosuximide on learning and memory: a behavioral and biochemical study on nonepileptic rats","volume":"17","author":"Ponnusamy","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1525-5050(03)00122-7","article-title":"Levetiracetam monotherapy during pregnancy: a case series","volume":"4","author":"Long","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","article-title":"Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers","volume":"80","author":"Mawhinney","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0185","series-title":"The zebrafish book: a guide for the laboratory use of zebrafish (Danio rerio)","author":"Westerfield","year":"2007"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0190","series-title":"Guideline for the testing of chemicals. Draft proposal for a new guideline Fish Embryo Toxicity (FET) test","author":"OECD","year":"2006"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0195","series-title":"EU. Directive 2010\/63\/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes","first-page":"33","volume":"vol. 276","author":"European Commission (EC)","year":"2010"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2007.03.015","article-title":"Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants","volume":"75","author":"Berghmans","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2011.01.004","article-title":"Zebrafish (Danio rerio) embryos as a model for testing proteratogens","volume":"281","author":"Weigt","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ecoenv.2004.10.015","article-title":"Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals","volume":"63","author":"Fraysse","year":"2006","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0215","series-title":"Basivalidierung genormter verfahre zur wasser-,abwasser-,und schlammuntersuchung validierungsdokument (38415-T6)","first-page":"27","author":"DIN","year":"2002"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0024-3205(95)00242-X","article-title":"Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy","volume":"57","author":"Nau","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0225","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2008.09.002","article-title":"Retinoic acid synthesis and signaling during early organogenesis","volume":"134","author":"Duester","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0230","first-page":"7","article-title":"Valproic acid downregulates RBP4 and elicits hypervitaminosis a-teratogenesis\u2014a kinetic analysis on retinol\/retinoic acid homeostatic system","author":"Chuang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nprot.2007.514","article-title":"High-resolution in situ hybridization to whole-mount zebrafish embryos","volume":"3","author":"Thisse","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00018-005-5348-0","article-title":"Antiepileptic drugs and the developing brain","volume":"63","author":"Kaindl","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2014a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0250","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.39.4.251","article-title":"Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth","volume":"39","author":"Dean","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.reprotox.2013.06.001","article-title":"Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function","volume":"41","author":"Rihtman","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0890-6238(97)00152-4","article-title":"Embryotoxicity of carbamazepine in rat postimplantation embryo culture after in vitro exposure via three different routes","volume":"12","author":"Piersma","year":"1998","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0270","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0275","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0041-008X(77)90108-9","article-title":"A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice","volume":"40","author":"Sullivan","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/WNL.0b013e3182088297","article-title":"Child development following in utero exposure: levetiracetam vs sodium valproate","volume":"76","author":"Shallcross","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0285","first-page":"e31","article-title":"ADMETox in zebrafish","volume":"10","author":"Diekmann","year":"2013","journal-title":"Drug Discov Today: Dis Models"},{"key":"10.1016\/j.reprotox.2014.07.082_bib0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mod.2004.02.008","article-title":"Feedback mechanisms regulate retinoic acid production and degradation in the zebrafish embryo","volume":"121","author":"Dobbs-McAuliffe","year":"2004","journal-title":"Mech Dev"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623814002032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623814002032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:26Z","timestamp":1760189906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623814002032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":58,"alternative-id":["S0890623814002032"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2014.07.082","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2014.07.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}